Form 4: Veracyte Director Eliav Barr Reports Acquisition and Disposal of Common Stock

Director Eliav Barr reports acquiring and disposing of Veracyte, Inc. common stock and receiving restricted stock units.

Summary

• On June 13, 2024, Eliav Barr, a director of Veracyte, Inc., reported acquiring 11,473 shares of common stock at $0 and disposing of 41,868 shares.
• Following these transactions, Barr beneficially owns 41,868 shares of Veracyte common stock.
• Barr was also awarded restricted stock units on June 13, 2024, which vest in full on the first anniversary of the grant date or immediately prior to the company's next annual meeting of stockholders, if earlier, and also vest in full in the event of a change in control of the Issuer.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard disclosure of stock transactions by a company director. There is no indication of positive or negative sentiment.

Positives

• The granting of restricted stock units to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.

Future Outlook

The restricted stock units vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier, and also vest in full in the event of a change in control of the Issuer.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. Investors monitor these filings to gain insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders as they provide insight into the director's holdings and incentives.

Key Dates